BR9810097A - Derivados de macrolìdeos c-4-substituìdos - Google Patents

Derivados de macrolìdeos c-4-substituìdos

Info

Publication number
BR9810097A
BR9810097A BR9810097-1A BR9810097A BR9810097A BR 9810097 A BR9810097 A BR 9810097A BR 9810097 A BR9810097 A BR 9810097A BR 9810097 A BR9810097 A BR 9810097A
Authority
BR
Brazil
Prior art keywords
formula
compounds
derivatives
relates
substituted
Prior art date
Application number
BR9810097-1A
Other languages
English (en)
Inventor
Brian Scott Bronk
Takushi Kaneko
Michael Anthony Letavic
Hengmiao Cheng
Edward Alan Glazer
Bingwei Vera Yang
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9810097A publication Critical patent/BR9810097A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de Invenção: <D>"DERIVADOS DE MACROLìDEOS C-4"-SUBSTITUìDOS"<D>. Esta invenção refere-se a compostos da fórmula (1) ou seus sais farmaceuticamente aceitáveis. Os compostos de fórmula (1) são agentes antibacterianos potentes que podem ser utilizados para tratar várias infecções bacterianas e distúrbios relacionadas com tais infecções. A invenção refere-se também composições farmacêuticas contendo os compostos de fórmula (1) e os métodos para tratar infecções bacterianas através da administração de compostos de fórmula (1). A invenção refere-se ainda com métodos de preparação dos compostos de fórmula (1) e intermediários úteis em tal preparação.
BR9810097-1A 1997-06-11 1998-05-25 Derivados de macrolìdeos c-4-substituìdos BR9810097A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11
PCT/IB1998/000799 WO1998056801A1 (en) 1997-06-11 1998-05-25 C-4''-substituted macrolide derivatives

Publications (1)

Publication Number Publication Date
BR9810097A true BR9810097A (pt) 2000-08-08

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810097-1A BR9810097A (pt) 1997-06-11 1998-05-25 Derivados de macrolìdeos c-4-substituìdos

Country Status (39)

Country Link
EP (1) EP0988309B1 (pt)
JP (1) JP3262806B2 (pt)
KR (1) KR100369959B1 (pt)
CN (1) CN1145636C (pt)
AP (1) AP1189A (pt)
AR (1) AR013085A1 (pt)
AT (1) ATE310742T1 (pt)
AU (1) AU745006C (pt)
BG (1) BG64357B1 (pt)
BR (1) BR9810097A (pt)
CA (1) CA2293397C (pt)
CO (1) CO4950584A1 (pt)
DE (1) DE69832486T2 (pt)
DZ (1) DZ2515A1 (pt)
EA (1) EA002440B1 (pt)
ES (1) ES2251081T3 (pt)
GT (1) GT199800075A (pt)
HN (1) HN1998000074A (pt)
HR (1) HRP980315A2 (pt)
HU (1) HUP0004076A3 (pt)
ID (1) ID24530A (pt)
IL (1) IL132808A (pt)
IS (1) IS1979B (pt)
MA (1) MA24563A1 (pt)
MY (1) MY133027A (pt)
NO (1) NO315560B1 (pt)
NZ (1) NZ500652A (pt)
OA (1) OA11226A (pt)
PA (1) PA8452001A1 (pt)
PE (1) PE79999A1 (pt)
PL (1) PL337497A1 (pt)
SK (1) SK168299A3 (pt)
TN (1) TNSN98084A1 (pt)
TW (2) TW200418871A (pt)
UA (1) UA70298C2 (pt)
UY (1) UY25041A1 (pt)
WO (1) WO1998056801A1 (pt)
YU (1) YU62999A (pt)
ZA (1) ZA985016B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
DK1011689T3 (da) * 1997-09-10 2007-05-21 Merial Ltd Anvendelse af 9a-azalider som veterinære antimikrobielle midler
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
KR20010083944A (ko) 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
PT1206476E (pt) * 1999-08-24 2006-05-31 Abbott Lab 9a-azalidos com actividade antibacteriana
MXPA02007305A (es) * 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
JP4104463B2 (ja) * 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
PL374646A1 (en) * 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
US7157433B2 (en) 2002-07-08 2007-01-02 Glaxosmithkline Istrazivacki Centar Zagreb Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
RU2330858C2 (ru) 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
ES2552682T3 (es) * 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
AU2009308182B2 (en) 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN103080121B (zh) * 2010-09-20 2015-11-25 瑞士诺华动物保健有限公司 用于制备在二脱氧甲基己糖环的C-4”处被环氧基团修饰的9-脱氧-9a-氮杂-9a-高红霉素A的新方法
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
US9982005B2 (en) * 2013-04-04 2018-05-29 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
KR20220156570A (ko) * 2020-03-12 2022-11-25 조에티스 서비시즈 엘엘씨 면역조절성 유레아 아잘라이드

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
GT199800075A (es) 1999-11-30
KR20010013633A (ko) 2001-02-26
CA2293397A1 (en) 1998-12-17
CN1145636C (zh) 2004-04-14
BG103969A (en) 2000-07-31
BG64357B1 (bg) 2004-11-30
OA11226A (en) 2003-07-16
ID24530A (id) 2000-07-20
WO1998056801A1 (en) 1998-12-17
HK1025974A1 (en) 2000-12-01
AR013085A1 (es) 2000-12-13
EA002440B1 (ru) 2002-04-25
KR100369959B1 (ko) 2003-02-12
EP0988309A1 (en) 2000-03-29
CN1259955A (zh) 2000-07-12
NO996107L (no) 2000-02-10
AP1189A (en) 2003-07-16
CO4950584A1 (es) 2000-09-01
HRP980315A2 (en) 1999-04-30
PE79999A1 (es) 1999-08-25
TWI224106B (en) 2004-11-21
JP3262806B2 (ja) 2002-03-04
IS1979B (is) 2005-01-14
AU7228198A (en) 1998-12-30
EP0988309B1 (en) 2005-11-23
EA199901014A1 (ru) 2000-06-26
MA24563A1 (fr) 1998-12-31
PA8452001A1 (es) 2000-05-24
TNSN98084A1 (fr) 2005-03-15
UA70298A (uk) 2004-10-15
IL132808A (en) 2004-08-31
AU745006C (en) 2006-02-23
DE69832486T2 (de) 2006-07-27
DE69832486D1 (de) 2005-12-29
HUP0004076A2 (hu) 2001-04-28
CA2293397C (en) 2004-08-31
PL337497A1 (en) 2000-08-28
TW200418871A (en) 2004-10-01
ZA985016B (en) 1999-12-10
NO996107D0 (no) 1999-12-10
YU62999A (sh) 2002-10-18
IS5250A (is) 1999-11-16
IL132808A0 (en) 2001-03-19
JP2000514097A (ja) 2000-10-24
NO315560B1 (no) 2003-09-22
HUP0004076A3 (en) 2003-05-28
AU745006B2 (en) 2002-03-07
ATE310742T1 (de) 2005-12-15
UA70298C2 (uk) 2004-10-15
SK168299A3 (en) 2000-09-12
UY25041A1 (es) 2000-09-29
NZ500652A (en) 2001-10-26
AP9801254A0 (en) 1998-06-30
HN1998000074A (es) 1999-01-08
ES2251081T3 (es) 2006-04-16
MY133027A (en) 2007-10-31
DZ2515A1 (fr) 2003-02-01

Similar Documents

Publication Publication Date Title
BR9810097A (pt) Derivados de macrolìdeos c-4-substituìdos
BRPI9810519A (pt) derivados de 4&#39;&#39;-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
BR9802851A (pt) Antibióticos de macrolìdeo substituìdos por c-4
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR9814601A (pt) &#34;macrólidos&#34;
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
BR9915480A (pt) Azalìdeos de 13 membros e a sua utilização como agentes antibióticos
BRPI0201437B8 (pt) processos para a preparação de derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4&#34;-substituídos
BR9800228A (pt) Compostos de peridilfurano e piridiltiofeno
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9709959A (pt) Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
BR0010938A (pt) Derivados da 13-metil eritromicina
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BR9914998A (pt) Antibióticos macrólidos
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
BR9903737A (pt) Carbamatos em c-11 de macrólidos antibacterianos
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
BR9812148A (pt) Derivados de eritromicina 6,9-ligados em ponte
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
BR9910206A (pt) Derivados de higromicina a.
BR9915813A (pt) Derivados da higromicina a como agentes antibacterianos
BR9910232A (pt) Derivados de 2-desóxi-higromicina
BR9809489A (pt) Composto, processo para preparar o mesmo, e, composição farmacêutica e processo para tratar infecções bacterianas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A,9A E 10A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009.